Atlas Trials

Stage II Bladder Urothelial Carcinoma

7 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Stage II Bladder Urothelial Carcinoma

RecordFirmDate
Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations (NCT03609216)Alliance for Clinical Trials in Oncology2018-12-10
Circulating Tumor Cells in Operative Blood in Patients With Bladder Cancer (NCT02514408)University of Southern California2018-02-05
Robot-Assisted Laparoscopic High-Intensity Focused Ultrasound and Radical Cystectomy for Thermal Ablation of Muscle Invasive Cells in Patients With Bladder Tumors (NCT03238664)University of Southern California2018-01-22
Gemcitabine Hydrochloride, Cisplatin, and AGS-003-BLD in Treating Patients With Muscle-Invasive Bladder Cancer Undergoing Surgery (NCT02944357)Mayo Clinic2016-11-01
sEphB4-HSA Before Surgery in Treating Patients With Bladder Cancer, Prostate Cancer, or Kidney Cancer (NCT02767921)University of Southern California2016-08-02
Robotic or Open Radical Cystectomy in Treating Patients With Bladder Cancer (NCT02699853)University of Southern California2016-04-12
Ultrasound and Biomarker Tests in Predicting Cancer Aggressiveness in Tissue Samples of Patients With Bladder Cancer (NCT02494635)University of Southern California2015-09-16

Track Stage II Bladder Urothelial Carcinoma automatically

Every clearance here is in the API, with alerts when new ones post.